Blood viscosity in ARDS: a look at how thick the blood is
Official title: Assessment of Blood Viscosity in ARDS
Run by Hospices Civils de Lyon · NCT07823296 · Data updated 2026-11-12
This study tests whether blood viscosity is higher in adults with ARDS and whether viscosity relates to their breathing and blood flow issues.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 46 (estimated) |
| Sponsor | Hospices Civils de Lyon Academic / other |
| Locations | 1 site (Lyon) |
| Status | Recruiting |
| Started | October 27, 2026 |
| Main results expected | January 1, 2028 |
| Study ends | January 1, 2028 |
| Registry record updated | November 6, 2026 |
| Trial ID | NCT07823296 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 years and older with moderate-to-severe ARDS (PaO2/FiO2 ≤ 200 mmHg) meeting inclusion criteria and able to provide consent (patient or surrogate).
✕Probably not a fit
Patients with ARDS longer than 72 hours, those with recent transfusions or certain blood conditions, or those with high bleeding risk may not benefit or be excluded from the study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study compares blood viscosity and its determinants in adults with moderate-to-severe ARDS to a control group without ARDS. It collects blood samples from peripheral veins and from arterial/central lines to measure viscosity-related parameters. The goal is to see if hyperviscosity is present in ARDS and whether it correlates with respiratory and hemodynamic changes. The study is conducted at Hopital de la Croix-Rousse in Lyon under the Hospices Civils de Lyon as the lead sponsor. Participants include adults 18 and older with ARDS meeting specific criteria or eligible controls who consent to participate.
Why it matters
Potential benefit: If hyperviscosity is found to be linked to ARDS severity, this could inform future therapies aimed at normalizing blood viscosity to improve outcomes.
How similar studies have gone: Previous work has examined deformability in ARDS, but comprehensive blood viscosity parameter assessment in ARDS is not well studied.
Who can join: the full rules
Show full inclusion / exclusion criteria
Case Group Inclusion Criteria: * Age ≥ 18 ans * Moderate-to-severe ARDS according to the global definition: * with PaO₂/FiO₂ ≤ 200 mmHg (based on arterial blood gas analysis in patients receiving invasive or non-invasive mechanical ventilation or high-flow nasal oxygen therapy). * Participation agreement obtained (either from the patient themselves or from a relative) Exclusion Criteria: * ARDS that has been present for more than 72 hours * Terminally ill patient with death expected within 24 hours * Patient who has received a blood transfusion within the past month * Patient with a known hematologic malignancy (lymphoma; myeloma; acute or chronic leukemia) * Patient with a known hemoglobinopathy. * Hemorrhagic shock * Hemoglobin \< 70 g/dL Control group Inclusion Criteria: * Age ≥ 18 ans * Participation agreement obtained (either from the patient themselves or from a relative) Exclusion Criteria: * Presence of ARDS according to the global definition * P/F \< 300 mmHg * Presence of sepsis defined by an infection and a SOFA score delta ≥ 2. * Terminally ill patient with death expected within 24 hours * Patient who has received a blood transfusion within the past month * Patient with a known hematologic malignancy (lymphoma; myeloma; acute or chronic leukemia) * Patient with a known hemoglobinopathy. * Hemorrhagic shock * Hemoglobin \< 70 g/dL
Where it's running
-
Hopital de la Croix-Rousse
Lyon, France Recruiting
Study contacts
- Study coordinator: Hippolyte LEQUAIN, Dr
- Email: hippolyte.lequain@chu-lyon.fr
- Phone: 0472071281
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Multicenter group study of sepsis and ARDS in China
This study tests how sepsis and ARDS differ among adults across several Chinese hospitals and builds a biobank to understand why some patients do better or worse.
-
TwitchView-guided Atracurium Dose Adjustment in ICU Patients
This trial tests whether using a TwitchView EMG monitor to guide atracurium dosing in ICU patients reduces the total amount of the drug given without compromising care.
-
Fibrinogen-to-Albumin Ratio as a Predictor of ARDS in Traumatic Brain Injury
This study tests whether the fibrinogen-to-albumin ratio can predict who among adults with traumatic brain injury will develop acute respiratory distress syndrome (ARDS).
-
Gastric versus postpyloric feeding for adults with ARDS on prone ventilation
This trial will test whether feeding through a stomach tube (nasogastric) or a tube placed past the stomach (nasojejunal) works better for adults with moderate to severe ARDS who are on a ventilator and positioned face-down.
-
Using higher PEEP with mask noninvasive ventilation for people with pneumonia or ARDS
This trial will test whether giving higher PEEP through a mask during noninvasive ventilation helps adults with pneumonia or ARDS avoid intubation and improve oxygenation.
-
Personalized lung volume optimization with PEEP titration for children after heart surgery or with severe respiratory failure
This trial tests whether a personalized lung volume optimization maneuver using PEEP titration can improve heart and lung function in children after cardiopulmonary bypass surgery or in those with severe respiratory failure at risk for ECMO.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.